Profile banner
Moaraj Hasan

Moaraj Hasan

Proteomics | I build longevity focused companies

moaraj-hasan
San Francisco, California, United States
Joined January 2025

Network

8.4K connections
🧬
Seer Proteomics & Data
💻
Roche Computational Scientists
💡
Biotech Founders & Advisors
🎓
Academic Research Leaders
📣
Biotech Product & Marketing
💰
Venture Capital
📈
Alamar Sales & Operations

Summary

Moaraj Hasan is deeply involved in the intersection of proteomics, AI, and longevity. He is currently working on "Secret Very Cool Proteomics and AI Stuff" at a stealth mode biotech company, focusing on building longevity-focused companies. His previous role at Seer, Inc. as a Proteomics Wizard, and involvement in Alzheimer's drug development at Reservoir Neuroscience, further highlight his commitment to extending healthy human lifespan through scientific innovation. rocketreach
Moaraj is an accomplished researcher with a strong background in mass spectrometry, nanotechnology, and systems biology. His work at Seer, ETH Zürich, and Harvard Medical School involved cutting-edge research in engineered nanoparticles for deep proteomics studies, multiomic profiling, and targeted nanotherapeutics. He has co-authored numerous publications and patents, with a Google Scholar h-index of 9 and i10-index of 9. google+2
Moaraj's career demonstrates a blend of scientific expertise and business acumen. Beyond his research roles, he has experience as a Venture Associate at Roche and was involved in building a startup at Reservoir Neuroscience. This combination of scientific depth and entrepreneurial spirit positions him uniquely in the biotech and longevity sectors.
Moaraj has a strong academic foundation from prestigious institutions including the University of Waterloo (B.S. Chemistry), ETH Zürich (M.S. Systems Biology, Proteomics, Bioinformatics), and Harvard University (PhD). His master's thesis work under Professor Ruedi Aebersold, a pioneer in proteomics, signifies his early engagement with leading-edge scientific research. google

Work

Education

Writing

Particles and methods of assaying

January 1, 2025

A patent application detailing particles and methods for assaying.

Favicon imagescholar.google.com

Apparatus for biomolecule assay

January 1, 2024

A patent application describing an apparatus for biomolecule assay.

Favicon imagescholar.google.com

Enhanced Competition at the Nano–Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes

August 1, 2022

Demonstrates the importance of the protein to nanoparticle-surface ratio (P/NP) in modulating protein corona composition and enhancing the depth and precision of nanoparticle-based deep proteomic workflows. The study highlights how increasing binding competition on engineered nanoparticles identifies significantly more proteins and suggests P/NP plays a critical role in nanomedicine applications.

Favicon imageonlinelibrary.wiley.com

Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano–bio interactions

January 1, 2022

Describes a method for deep profiling of the plasma proteome using surface-functionalized superparamagnetic nanoparticles, achieving superior precision, depth, and throughput compared to traditional approaches. It details how machine learning is used to analyze nanoparticle physicochemical properties and protein corona composition.

Favicon imagepmc.ncbi.nlm.nih.gov

Quantifying and localizing the mitochondrial proteome across five tissues in a mouse population

January 1, 2018

Investigates the mitochondrial proteome across various tissues in a mouse population, quantifying and localizing proteins.

Favicon imagescholar.google.com

Assessing physicochemical properties of drug molecules via microsolvation measurements with differential mobility spectrometry

January 1, 2017

Focuses on evaluating the physicochemical properties of drug molecules through microsolvation measurements combined with differential mobility spectrometry.

Favicon imagescholar.google.com

Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis

January 1, 2016

Details the development of targeted interleukin-10 nanotherapeutics using a microfluidic chip, which improves the resolution of inflammation in advanced atherosclerosis.

Favicon imagescholar.google.com

Persistent intramolecular C–H··· X (X= O or S) hydrogen-bonding in benzyl meldrum’s acid derivatives

January 1, 2014

Researches persistent intramolecular hydrogen-bonding in benzyl meldrum's acid derivatives, contributing to fundamental chemistry.

Favicon imagescholar.google.com